Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience is advancing its DehydraTECH drug delivery platform to compete in the booming GLP-1 market, which is dominated by Novo Nordisk’s ...
(RTTNews) - Friday, Precision BioSciences, Inc. (DTIL) announced a 1-for-30 reverse stock split of its common stock, effective February 13, 2024, after the close of trading on The Nasdaq Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results